Ivantis Company
%20.jpg)
Ivantis, Inc. is a company focused on developing an innovative treatment for Glaucoma. It is their goal to develop a less invasive, more effective option for the 60+ million people worldwide suffering from Primary Open Angle Glaucoma. As they successfully address this initial goal, it is then there intention to focus on innovative development for the treatment of other debilitating diseases within ophthalmology.
Investors
(INV)%20.jpg)
Funding Status:
Late Stage Venture
Headquarters:
Irvine, California, United States
Founded Date:
2007-01-01
Employee Number:
101-250
Last Funding Type:
Series C
Total Funding:
$132.4M
Estimated Revenue:
$10M to $50M
Industry:
Health Care, Health Diagnostics, Medical Device
Investors Number:
16
Technology:
P4 Medicine
Investor Type:
For Profit